Clinical Outcomes of Bail-Out Stenting After Drug-Coated Balloon Angioplasty: The International Multicenter BAILOUT Registry

BACKGROUND: Drug-coated balloons (DCBs) are increasingly adopted in percutaneous coronary intervention. Bail-out drug-eluting stent (DES) implantation due to suboptimal immediate results after DCB angioplasty is not infrequent, and the clinical outcomes of percutaneous coronary intervention with DCB angioplasty followed by bail-out DES implantation remain unexplored. The aim of this study was to evaluate the safety of bail-out DES implantation following DCB angioplasty in percutaneous coronary intervention. METHODS: The BAILOUT registry included consecutive patients undergoing bail-out DES implantation after DCB angioplasty at 17 European centers between 2011 and 2024. The primary end point was target lesion failure (TLF) at 1 year, defined as the composite of target lesion revascularization, target vessel myocardial infarction, and cardiac death. The TLF rate was compared with a performance goal of 7.0% for an upfront DES-only strategy, derived from a meta-analysis of contemporary randomized controlled trials. RESULTS: =0.048). CONCLUSIONS: In cases of suboptimal angiographic results after DCB angioplasty, bail-out DES implantation is safe, with no increased risk of TLF at 1 year compared with the expected performance goal for an upfront DES-only strategy.

Authors

Institutions

Publication Details

Journal
Circulation Cardiovascular Interventions
Published
2026-04-30
DOI
https://doi.org/10.1161/circinterventions.125.016461
Primary Topic
Coronary Interventions and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Outcomes of Bail-Out Stenting After Drug-Coated Balloon Angioplasty: The International Multicenter BAILOUT Registry

Tuomas T. Rissanen, Simon Eccleshall, Elodi Bacci, Ioannis Merinopoulos et al.
Circulation Cardiovascular Interventions
Coronary Interventions and Diagnostics
article

Clinical Outcomes of Bail-Out Stenting After Drug-Coated Balloon Angioplasty: The International Multicenter BAILOUT Registry

Tuomas T. Rissanen, Simon Eccleshall, Elodi Bacci, Ioannis Merinopoulos, Kasper Kyhl, Michele Galasso, Alfonso Ielasi, Marco FERRONE, Michele Morosato, Natasha Corballis, Diego Arroyo, Jonathan Hinton, Francesca De Micco, Thomas Johnson, Gianmaria Calamita, Marcello Marchetta, Siamion Pismiankou, Guido Vellucci, F Ugo, Giuseppe Massimo Sangiorgi, S Galli, M L Rossi, D Maffeo, C Briguori, M Sabate, D Regazzoli, Mauro Chiarito, Vassilios S Vassiliou, Antonio Mangieri, Pier Pasquale Leone, Mauro Gitto, Tullio Tesorio, Luigi Salemme, Kambis Mashayekhi, Fernando Alfonso, Peter O'Kane, Giovanni Occhipinti, Giulio G Stefanini, Gabriele Gasparini, Francesco Tartaglia, Andrea Buono, Antonio Colombo, Azeem Latib, Bernhard Reimers
article en

Abstract

BACKGROUND: Drug-coated balloons (DCBs) are increasingly adopted in percutaneous coronary intervention. Bail-out drug-eluting stent (DES) implantation due to suboptimal immediate results after DCB angioplasty is not infrequent, and the clinical outcomes of percutaneous coronary intervention with DCB angioplasty followed by bail-out DES implantation remain unexplored. The aim of this study was to evaluate the safety of bail-out DES implantation following DCB angioplasty in percutaneous coronary intervention. METHODS: The BAILOUT registry included consecutive patients undergoing bail-out DES implantation after DCB angioplasty at 17 European centers between 2011 and 2024. The primary end point was target lesion failure (TLF) at 1 year, defined as the composite of target lesion revascularization, target vessel myocardial infarction, and cardiac death. The TLF rate was compared with a performance goal of 7.0% for an upfront DES-only strategy, derived from a meta-analysis of contemporary randomized controlled trials. RESULTS: =0.048). CONCLUSIONS: In cases of suboptimal angiographic results after DCB angioplasty, bail-out DES implantation is safe, with no increased risk of TLF at 1 year compared with the expected performance goal for an upfront DES-only strategy.

Circulation Cardiovascular Interventions
University of Rome Tor Vergata (IT), Dorset HealthCare University NHS Foundation Trust (GB), Albert Einstein College of Medicine (US), Montefiore Medical Center (US), Humanitas University (IT), University of Fribourg (CH), Norfolk and Norwich University Hospital (GB), University Hospitals Bristol NHS Foundation Trust (GB), Zealand University Hospital (DK), Mercy Clinic Neurology (US), Centro Cardiologico Monzino (IT), North Karelia Central Hospital (FI), EMO GVM Centro Cuore Columbus (IT), Istituto Clinico Sant'Ambrogio (IT), CTO Andrea Alesini (IT), Clinica Mediterranea (IT), Hospital Universitario de La Princesa (ES), Fondazione Poliambulanza Istituto Ospedaliero (IT), Deutsches Herzzentrum München (DE), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), IRCCS Humanitas Research Hospital (IT)
Good health and well-being
Openalex Percentile: Top 13%
Coronary Interventions and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.